Recon: House lawmakers push FDA to probe clinical studies conducted in China; J&J to buy V-Wave for up to $1.7B

• J&J to buy heart failure implant maker V-Wave for up to $1.7B (MedTech Dive) (Endpoints)
• Congressional probe questions clinical trials run in China, citing Army involvement (STAT)
• What to know about Alnylam’s upcoming readout on its heart drug (STAT)
• Abortion rights and drug pricing program take spotlight at first night of DNC (STAT)
• Q&A: How the FDA could use AI for drug and device safety surveillance (STAT)
• Big employers are spending even more money on pharmacy costs, driven by GLP-1s and other high-cost therapies, survey says (Endpoints)
• FDA Disruption: If Trump Wins, Could Big Changes Be Coming? (Pink Sheet)
• AstraZeneca’s Imfinzi Squeezes Through: Is FDA Reversing Course Or In A Transition Period? (Pink Sheet)

• Improving the FDA-EMA parallel scientific advice program to advance complex generics (STAT)
• Emergent joins broader efforts for mpox vaccine drive in Africa (Endpoints)
• UK Medicines Agency Wants ‘Up To Five Years’ Notice Of New Applications (Pink Sheet)
• ICH Explores New Platform To Facilitate Global Evaluation Of CMC Changes (Pink Sheet)
• EU Warns Of Anaphylaxis With MS Drug ‘Months Or Years’ After Start Of Treatment (Pink Sheet)
• Brexit & Covid Impact On UK Cancer Trials ‘Dissipating’ (Pink Sheet)

• Does Ozempic increase the risk of suicidal thoughts? A new study muddles the picture (STAT)
• Lilly’s Zepbound slashed risk of developing diabetes (STAT)\
• Kymera seeks to raise $225M; Adcendo, Multitude's new ADC deal (Endpoints)
• TCGX and JPM help Pathalys raise $105M to go up against Amgen in subset of kidney disease (Endpoints)
• FDA rebukes another troubled Eugia production site with a warning letter (Fierce Pharma)

• Medtronic: Diabetes strategy hasn’t changed amid Abbott partnership (MedTech Dive)
• Histosonics raises $102M for noninvasive treatment to destroy tumors (MedTech Dive)
• Edwards continues M&A spree with Genesis’ TAVR tech (MedTech Dive)
• FDA OKs first at-home syphilis test (MedTech Dive)
• DuPont acquires Donatelle Plastics for $313M (MedTech Dive)
• European Commission Publishes Links To Notified Bodies’ Medtech Fees (MedTech Insight)
• Neptune Medical Leans Into GI Robotics, Spins Out Jupiter Endovascular (MedTech Insight)
• Moximed Secures $91M To Scale Commercialization Of MISHA Knee System (MedTech Insight)
• Cresilon’s FDA-Cleared Traumagel Stops Severe Bleeding Instantly, Available In US In Late 2024 (MedTech Insight)

• Teamwork is good for science — but maybe not for young researchers’ careers (STAT)
• Teva faces fresh Copaxone kickbacks case from Medicare providers as it defends against DOJ claims (Fierce Pharma)